Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recipharm invests in fill finish capacity

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The facility will be constructed on a greenfield site near Dehradun in Uttarakhand and is a joint project between Recipharm and the Sobti family. The new site, which is designed for approval to supply the EU and US is now ready to begin production following approval from the local authorities. It will be delivering ampoules, vials filled with liquid and

Tim Hortons® announce opening date for new Drive-Thru Restaurant in Chester

Tim Hortons [®], the iconic Canadian coffee chain, will open a new drive-thru restaurant at Chester Retail Park on Saturday 31[st] July at 7am.The location will offer both a warm, welcoming and comfortable restaurant, as well as a drive thru lane for everyone to enjoy Canada’s favourite coffee*. To celebrate, the first fan in the drive thru and restaurant queue will win a VIP Coffee Card which entitles them to two free medium coffees for a whole year, a prize worth a staggering £3,100. The brand will also be giving away free breakfast meals for the

Qlife has submitted a scientific study of the company's COVID-19 test for peer-review to be published in an international journal

Qlife announces today that a scientific study of the company's COVID-19 test has been submitted to Natures Scientific Reports for publication. The study demonstrates the potential of Qlife's mobile test platform Egoo.Health and COVID-19 tests that can deliver exactly the same clinical quality as laboratory tests in 30 minutes.Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24 hours from test to diagnosis. The study, which has been submitted to

Half-year report January – June 2021

Summary January – June 2021· Rental income increased 9 per cent to SEK 1,751 million (1,608). · Profit from property management increased 9 per cent to SEK 1,018 million (930). · Changes in value of properties amounted to SEK 2,504 million (333) and changes in value of financial instruments to SEK 112 million (-119).   · Profit after tax for the period increased to SEK 2,981 million (879). · Market value of investment properties amounted to SEK 69,619 million (57,533). · During the period 29 properties (17) were acquired for SEK 2,697 million (490) and 2 properties (4) were

Interim report Rejlers AB January – June 2021

April - June · Net sales increased by 25.6% to SEK 755.9 million (601.7) · Organic sales growth excluding exchange rate fluctuations increased to 13.5% (-2.3) · EBITA increased to SEK 53.0 million (15.3) and the EBITA margin increased to 7.0% (2.5) · EBITA for 2020 was impacted by a restructuring cost of SEK 18.4 million · Operating profit (EBIT) increased to SEK 46.6 million (9.2) and the operating margin increased to 6.2% (1.5) · Net financial items amounted to an expense of SEK 8.3 million (6.0) · Net profit after tax increased to SEK 31.4 million (0.8) ·

Self Storage Group ASA - Acquisition of property in Asker

(Oslo, July 15th 2021) Self Storage Group ASA (Self Storage Group, OSE: SSG) has entered into an agreement to acquire a property in Billingstadsletta 91 in Asker, Norway. Through the Eurobox transaction in 2019, SSG received the option right to acquire this property at attractive terms. The transaction has a property value of NOK 32.8 million, with an estimated lettable area of 3150 square meters. The transaction is expected to be closed during the 3rd quarter of 2021 and the facility is projected to open during 2022. The property has a central location at Billingstad in Asker. The

Notice of Extraordinary General Meeting in Nederman Holding AB (publ)

The shareholders of Nederman Holding AB (publ), Reg. No. 556576-4205, are hereby summoned to the Extraordinary General Meeting on Wednesday 25 August 2021.The board of directors has decided that the Extraordinary General Meeting should be conducted solely by way of postal vote pursuant to the temporary legislation being in effect in 2021. This means that the meeting will be held without the physical presence of shareholders, representatives or external parties. The shareholders will therefore only be able to exercise their voting rights by postal voting in the order prescribed below.

Valmet to deliver a semi-chemical pulp line to Lee & Man Paper Manufacturing Ltd, Chongqing in China

Valmet Oyj’s press release on July 15, 2021 at 11:00 a.m. EETValmet will supply a semi-chemical pulp (SCP) line to Lee & Man Paper Manufacturing Ltd, Chongqing in China. The technology deliveries by Valmet will begin in 2022 and the start-up is planned for 2023. The order is included in Valmet’s orders received of the second quarter 2021.The value of the order will not be disclosed. However, a project of this size and scope is typically valued at around EUR 10-20 million. “Our cooperation with Valmet has been good and we are convinced that the partnership and Valmet’s technology will

Medicover’s Q2 report 2021 and invitation to a conference call

Medicover’s (MCOV B) Q2 report 2021 will be published on 23 July at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. CEO Fredrik Rågmark and CFO Joe Ryan will present the report and take questions. Shortly before the webcast, presentation slides will be available on medicover.com . To join the conference call please dial-in using the following details at least 10 minutes before the start of the call: Sweden: +46 (0) 856 618 467 UK: +44 (0) 2071 928

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on July 22 at 9:30 CEST

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.To register for the presentation of the interim report for the period April – June 2021, which will be held on July 22 at 9.30 CEST, visit www.mentice.com/financial-reports-presentations The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

Spermosens patent granted by the European Patent Office

Spermosens AB today announces that the European Patent Office (EPO) has granted the patent EP 3 768 825, which protects the company’s biosensor and its use for in vitro fertilization. The formal grant follows the previous ”Intention to Grant”-notification communicated April 16[th] 2021.Based on EPO:s grant of the patent with number EP 3 768 825, a European protection exists until 2039 and encompasses the company’s biosensor product and its use for, e.g. detecting and quantifying sperm binding function, diagnosis of male infertility, and selection of sperms suitable for In Vitro

EasyPark and Volvo partners up for new parking features

The parking tech company EasyPark and Volvo Cars are launching a new cooperation, releasing a feature that will automate parking payments.The new feature seamlessly integrates EasyPark’s app into Volvo’s Android Automotive environment in the car models XC40 recharge, C40, and the 2022 models of XC60, S90, V90 (including 90 Cross Country). The innovation gives the driver several new features and possibilities that further improves the driving experience.– The innovative solutions that we create together with Volvo are the future of the digital parking experience. By integrating the

Final decision on Engebø operating license expected after summer

In November 2020, the Directorate of Mining confirmed that the appeals received in relation to the operating license for the Engebø Rutile and Garnet project did not provide any basis to revoke or change the decision, and informed that the matter had been forwarded to the Ministry of Trade, Industry and Fisheries for final decision on the appeals. Nordic Mining ASA (the "Company") has earlier communicated that a final decision should be expected in the first half of 2021. This has been delayed as result of revised priorities in the Ministry due to the Covid-19 pandemic, and the final

Getinge publishes Ethics & Compliance Report

To summarize Getinge’s activities within the ethics and compliance area, the company is today releasing its first report which describes focus areas in relation to Business Ethics and Responsible Leadership.At Getinge, responsible leadership means involving all employees to set the standard and acting as role models for ethical behavior and professional integrity. Activities in this area provide the conditions and requirements for Getinge’s employees to ensure busi­ness is conducted in an ethical and responsible manner. Doing responsible business in all relations, in the company’s own

Invitation to UPM’s webcast and press conference on half-year financial report 2021

(UPM, Helsinki, 15 July 2021 at 10:00 EEST) – UPM will publish its half-year financial report 2021 on 22 July 2021 at 09:30-10:00 EEST. After publishing the report will be available on the company website www.upm.com. A webcast and a conference call for analysts and investors in English language begins at 13:15 EEST. UPM’s financial results will be presented by the President and CEO Jussi Pesonen and CFO Tapio Korpeinen. All participants can view the webcast online at www.upm.com  or through this link , but

QUARTERLY REPORT, SECOND QUARTER 2021

Press release: Stockholm, July 15, 2021, 08.45 CET HIGHLIGHTS OF THE SECOND QUARTER 2021 · Net sales was 109 MSEK compared to the previous year 67 MSEK · EBITDA was 36 MSEK (0) · EBIT was 16 MSEK (-22) · Cash and cash equivalents were 52 MSEK (14) · Earnings per share was 0.05 SEK (-0.32) · The production was about 382 000 (406 000) ounces silver, 988 (1 067) ounces gold, 396 (321) tonnes lead, and 919 (722) tonnes zinc in concentrates · A total of 10 314 104 new shares were subscribed by the warrants of series 2020/2021 in May 2021 adding 19 MSEK new

Interim Report, January – June 2021

Period April 1 – June 30, 2021 · Net sales of SEK 143 m (100 m) · Recurring revenues of SEK 68 m (62 m) · which corresponds to % of net sales 48 % (62 %) · EBITDA SEK 58 m (24 m) · EBITDA margin 40 % (24 %) · EBIT 30 m (12 m) · EBIT margin 21 % (12 %) · Net profit SEK 23 m (9 m) · Net profit margin 16 % (9 %) · EPS before dilution SEK 0.42 (0.17) · Cash flow from operating activities SEK 11 m (36 m) · ACV SEK 9 m (3 m) · ARR SEK 280 m (238 m) Period January 1 – June 30, 2021 · Net sales of SEK 245 m (203 m) · Recurring revenues of SEK 135

Three healthcare providers in the Netherlands order joint digital pathology solution from Sectra

Linköping, Sweden and Almere, the Netherlands – July 15, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has received an order from three healthcare providers in the Netherlands for a joint digital pathology solution. Maastricht University Medical Center (MUMC+), Laurentius Hospital and VieCuri MC will form a regional network to enable them to share pathology cases and expertise more easily, leading to faster, more accurate diagnoses for patients.“This joint initiative is a textbook example of how technology can help realize a

INVITATION: INVISIO invites you to a conference call July 22 at 10:00 CEST

INVISIO is pleased to invite press, investors and analysts to a conference call on July at 10.00 CEST where CEO Lars Højgård Hansen will present the Interim Report January – June 2021.The conference call, which will be held in English, will begin with a presentation of the report followed by a Q&A session. The Interim Report January – June 2021 will be published on July 22, 2021, at 08:30 CEST.Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a

BEIJER REF Q2 2021

Strong second quarter   Second quarter Net sales increased by 36.6% in the second quarter compared to the same period last year and amounted to SEK 4,561 million (3,338). Organic growth was strong at 33.8%. Acquisition effects amounted to 6.4%, which is offset by currency effects amounting to -3.5%. EBITA amounted to SEK 431 million (253), corresponding to an EBITA margin of 9.4% (7.6%). The operating profit amounted to SEK 418 million (241), an increase of 73.5% compared with the previous year. The operating margin amounted to 9.2% (7.2%). Profit before tax was SEK 402

SSAB has launched an extensive research project in Finland to replace fossil fuels with renewable energy in steelmaking

SSAB has launched an extensive research project, FFS – Towards Fossil-free Steel, in Finland. In the project, SSAB will work together with industrial and research partners to explore different solutions and alternatives to produce fossil-free steel and thus the ways to withdraw entirely from the use fossil energy. SSAB Raahe siteSSAB aims to be completely fossil free and to remove the company’s fossil carbon dioxide emissions by 2045. In 2016, SSAB, LKAB and Vattenfall announced the HYBRIT initiative, where the blast furnace process, which causes around 90% of the carbon dioxide

BioStock: Cyxone is exploring new treatment possibilities for T20K

After identifying new therapeutic treatment possibilities for T20K, Cyxone has announced a research collaboration with the Medical University of Vienna to further validate these findings and to deepen the understanding of T20K’s mode of action. The aim of the project is to prepare for a clinical phase I study with the new administration form. BioStock reached out to COO Carl-Magnus Högerkorp and Non-Clinical Project Manager Sally Abdelmoaty for a comment.Read the full interview at biostock.se: https://www.biostock.se/en/cyxone-is-exploring-new-treatment-possibilities-for-t20k/ This is

Calliditas secures $75 million term loan facility

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the company has signed a loan agreement of up to the Euro equivalent of $75 million with Kreos Capital. Proceeds from the loan will be utilized for the launch of Calliditas’ lead product candidate Nefecon, if approved, as well as to support clinical development efforts and for general corporate purposes.The loan facility is divided into three tranches of $25 million each. Drawdown of the first $25 million tranche can be made until 31 December 2021 and will be available after the

Ayima Newsletter - July 2021

Hello and welcome to the first of a new generation of Ayima’s newsletter – Newsletter 2.0. We hope to make this a regular quarterly publication that will bring news of the company and the Industry to our investors, clients, staff and other interested industry people. We aim to give some insight into the amazing people at Ayima and the unique culture and working environment we have built over the years. This initial edition has an update on general post-pandemic working life at Ayima from our UK Managing Director, Nicky Applegarth as well as news of an exciting new department that will

There are no items matching the current filter
There are no more items matching the current filter
Back to top